Chemweb Events

PepTalk: The Protein Science Week 2014 Jan 13-17 2014
Conference: United States [in English]

Year-over-year PepTalk: The Protein Science Week continues to draws leaders of biotherapeutics from industry and academia pioneering the evolution of biologics. The international delegation is comprised of over 1,200 participants from 20+ countries. The 2014 event features an expanded antibody engineering focus, new biomanufacturing conferences, 1200+ expected participants, dedicated exhibit hall hours and networking functions, and interactive roundtable BuzZ sessions and panel discussions.

Event Location:
277 N. Avenidas Caballeros
Palm Springs, CA 92262
United States

Kris Waterman (send an email)
250 First Avenue
Needham, MA 02494
United States
Early registration: Friday, November 22, 2013
Posters: Friday, November 22, 2013
Keynote speakers:

Jim Wells, Ph.D., Professor, Pharmaceutical Chemistry and Cellular & Molecular Pharmacology, University of California, San Francisco;
K. Dane Wittrup, Ph.D., C.P. Dubbs Professor of Chemical Engineering and Biological Engineering, Massachusetts Institute of Technology;
Thorsten Lorenz, Ph.D., Principal Scientist, Integrated Biologics Profiling, Novartis Pharma AG;
Ira H. Pastan, M.D., Head, Molecular Biology, NCI, NIH;
Robert S. Kahn, M.D., CPI, Senior Safety Scientist, Early Clinical Development, Global Safety Risk Management, Genentech, Inc.;
Ulrik Nielsen, Ph.D., CSO, Merrimack Pharmaceuticals;
Hanns-Christian Mahler, Ph.D., Head Pharmaceutical Development & Supplies, Biologics EU, F. Hoffmann-La Roche;
Michael Pikal, Ph.D., Pfizer Distinguished Endowed Chair in Pharmaceutical Technology & Professor of Pharmaceutics, University of Connecticut;
Thomas Laue, Ph.D., Professor, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire;
Desmond G. Hunt, Ph.D., Senior Scientific Liaison, Department of Standards Development, United States Pharmacopoeia;
Lorenz M. Mayr, Ph.D., Vice President, Reagents & Assay Development, AstraZeneca, Inc.;
Sabine Geisse, Ph.D., Director/NLS, Novartis Institutes for BioMedical Research;
Yan-ping Yang, Ph.D., Director, Downstream Purification, Bioprocess Research & Development, Sanofi Pasteur;
Ian Hunt, Ph.D., Group Leader, Protein Sciences, Novartis;
Jerold Martin, MSc, Chairman, BPSA BoD and Technology (E+L) Committee;
Sadettin S. Ozturk, Ph.D., Head, Process and Analytical Development, MassBiologics;
Dennis Jenke, Ph.D., Baxter Distinguished Scientist, Technology Resources, Baxter Healthcare Corp.

Session titles:

To see a full program, please visit our website.


Current sponsors include: EMD Millipore, PerkinElmer, ProteinSimple, Althea, Ajinomoto, Bend Research, Catalent, Chemical Computing Group, DNA2.0, Entegris, and Lonza. To see a full list, please visit our website.